Citigroup Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $494
Benzinga Newsdesk 17 hours ago
Analyst RatingsNewsPrice Target
Citigroup analyst Joanne Wuensch maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $412 to $494.
Citigroup analyst Joanne Wuensch maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $412 to $494.